Press-release for stocks for kazia therapeutics limited

Prices are updated after-hours

PNOC Study in Childhood Brain Cancer Enrols First Patient
Published: 2021-11-11 (Crawled : 13:00) - prnewswire.com
KZIA | $0.379 9.47% 8.65% 300K

| -96.79% | O: -1.76% H: 0.59% C: -1.56%
cancer brain cancer enroll train

Evotec SE Reports Results for the First Nine Months 2021 and Provides Corporate Update
Published: 2021-11-11 (Crawled : 10:00) - biospace.com/
EVO | $7.15 -0.7% 19K

| -70.39% | O: -0.9% H: 1.52% C: -0.63%
EXAI | $4.24 -2.75% -2.83% 370K

| -79.41% | O: 0.0% H: 1.94% C: 1.12%
KZIA | $0.379 9.47% 8.65% 300K

| -96.79% | O: -1.76% H: 0.59% C: -1.56%
results

67%

33%

KUKE | $2.88 2.49% 7.64% 360K

CXM 4 | $11.34 -0.44% 4.27% 1.7M

RNR 4 | $224.74 0.85% 3.52% 310K

BSBR | $5.25 2.54% 0.38% 430K

DV | News | $29.43 -2.36% 0.24% 1.9M

JOE 4 | $54.88 1.22% 0.22% 210K

MUSA 4 | $417.23 1.06% 0.01% 170K

JBI 4 | $15.14 1.34% 0.0% 2.9M

SBS | $15.49 -1.59% -0.84% 4.6M

ML 4 | $69.13 -4.48% -1.64% 110K

Save your searches and get alerts when important news are released.